Skip to main content

The cyclical nature of potential new antibiotics

Modified cyclical peptides can form pores in lipid bilayers and could be valuable as broad specificity antibiotics.

Written byDavid Bruce
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

The continuing emergence of antibiotic resistant bacterial strains has highlighted the importance of identifying and developing new therapeutic agents. In 26 July Nature Sara Fernadez-Lopez and colleagues from the Skaggs Institute for Chemical Biology, California describe six- and eight-residue cyclic D,L-α-peptides that preferentially act upon the membranes of both Gram positive and Gram negative bacteria.

Fernadez-Lopez et al. observed that amphiphilic D,L-α-peptides having three consecutive hydrophilic residues and repeating L-tryptophan and D-leucine residues can self-assemble into tubular structures that span synthetic membranes. These structures allow the highly efficient transport of ions and other small species across lipid bilayers (Nature 2001, 412:452-455).

By using single negatively charged amino acid substitutions they were able to modify the activity of individual peptides and used these against a variety of pathogenic bacteria. In vitro testing with multiple resistant Staphylococcus aureus (MRSA) and Escherichia coli showed up to 20-fold increased anti-bacterial activity. In addition the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo